Audience Discussion: Harnessing NGS for Characterizing CRISPR Components & Drug Products
Time: 9:30 am
day: Conference Day One
Details:
- Applying NGS to verify sequence identity and detect impurities in CRISPR components such as synthetic guides and AAV constructs
- Ensuring product integrity and functionality through sequence-based analysis of editing efficiency and unintended modifications
